CM vs. KNSA
CM (Canadian Imperial Bank of Commerce) and KNSA (Kiniksa Pharmaceuticals, Ltd.) are both stocks. CM operates in Banks - Diversified (Financial Services), while KNSA operates in Biotechnology (Healthcare). Over the past 5 years, CM returned 20.06%/yr vs 29.69%/yr for KNSA. At a 0.16 correlation, their price movements are largely independent.
Performance
CM vs. KNSA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CM achieves a 24.28% return, which is significantly lower than KNSA's 33.60% return.
CM
- 1D
- -1.05%
- 1M
- -3.29%
- YTD
- 24.28%
- 6M
- 22.27%
- 1Y
- 67.98%
- 3Y*
- 43.12%
- 5Y*
- 20.06%
- 10Y*
- 17.15%
KNSA
- 1D
- 1.66%
- 1M
- 3.51%
- YTD
- 33.60%
- 6M
- 27.60%
- 1Y
- 93.78%
- 3Y*
- 52.43%
- 5Y*
- 29.69%
- 10Y*
- —
CM vs. KNSA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
CM Canadian Imperial Bank of Commerce | 24.28% | 49.02% | 37.83% | 27.23% | -25.71% | 42.29% | 9.25% | 19.22% | -13.74% |
KNSA Kiniksa Pharmaceuticals, Ltd. | 33.60% | 108.54% | 12.77% | 17.09% | 27.27% | -33.39% | 59.76% | -60.63% | 14.89% |
Correlation
The correlation between CM and KNSA is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since May 24, 2018 | 0.16 |
Fundamentals
CM:
$75.95B
KNSA:
$4.54B
CM:
CA$12.14
KNSA:
$0.92
CM:
13.01
KNSA:
59.85
CM:
1.61
KNSA:
0.58
CM:
2.07
KNSA:
5.80
CM:
1.84
KNSA:
7.50
CM:
CA$61.84B
KNSA:
$754.05M
CM:
CA$28.74B
KNSA:
$294.06M
CM:
CA$13.01B
KNSA:
$101.06M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CM vs. KNSA — Risk / Return Rank
CM
KNSA
CM vs. KNSA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Canadian Imperial Bank of Commerce (CM) and Kiniksa Pharmaceuticals, Ltd. (KNSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CM | KNSA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.37 | ||
| Sortino ratioReturn per unit of downside risk | +1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.61 | 1.41 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 6.43 | 4.63 | +1.80 |
| Martin ratioReturn relative to average drawdown | 25.18 | 16.35 | +8.83 |
Loading charts...
Drawdowns
CM vs. KNSA - Drawdown Comparison
The maximum CM drawdown since its inception was -71.70%, smaller than the maximum KNSA drawdown of -83.06%. Use the drawdown chart below to compare losses from any high point for CM and KNSA.
Loading charts...
Drawdown Indicators
| CM | KNSA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.70% | -83.06% | +11.36% |
Max Drawdown (1Y)Largest decline over 1 year | -10.79% | -21.12% | +10.33% |
Max Drawdown (3Y)Largest decline over 3 years | -19.47% | -34.14% | +14.67% |
Max Drawdown (5Y)Largest decline over 5 years | -40.61% | -53.17% | +12.56% |
Max Drawdown (10Y)Largest decline over 10 years | -47.82% | — | — |
Current DrawdownCurrent decline from peak | -3.53% | -7.35% | +3.82% |
Average DrawdownAverage peak-to-trough decline | -14.65% | -40.60% | +25.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.75% | 5.97% | -3.22% |
Volatility
CM vs. KNSA - Volatility Comparison
The current volatility for Canadian Imperial Bank of Commerce (CM) is 7.78%, while Kiniksa Pharmaceuticals, Ltd. (KNSA) has a volatility of 10.40%. This indicates that CM experiences smaller price fluctuations and is considered to be less risky than KNSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CM | KNSA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.78% | 10.40% | -2.62% |
Volatility (6M)Calculated over the trailing 6-month period | 16.02% | 34.02% | -18.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.03% | 43.03% | -24.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.41% | 53.48% | -32.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.61% | 63.93% | -41.32% |
Dividends
CM vs. KNSA - Dividend Comparison
CM's dividend yield for the trailing twelve months is around 2.65%, while KNSA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CM Canadian Imperial Bank of Commerce | 2.65% | 3.17% | 4.21% | 5.88% | 7.77% | 4.08% | 5.06% | 6.47% | 5.48% | 5.28% | 5.93% | 6.71% |
KNSA Kiniksa Pharmaceuticals, Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CM vs. KNSA - Financials Comparison
This section allows you to compare key financial metrics between Canadian Imperial Bank of Commerce and Kiniksa Pharmaceuticals, Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CM vs. KNSA - Profitability Comparison
CM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Canadian Imperial Bank of Commerce reported a gross profit of 7.36B and revenue of 15.22B. Therefore, the gross margin over that period was 48.4%.
KNSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.
CM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Canadian Imperial Bank of Commerce reported an operating income of 3.20B and revenue of 15.22B, resulting in an operating margin of 21.0%.
KNSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.
CM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Canadian Imperial Bank of Commerce reported a net income of 2.46B and revenue of 15.22B, resulting in a net margin of 16.1%.
KNSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.
Frequently Asked Questions
CM and KNSA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KNSA has higher volatility (10.40%) compared to CM (7.78%). In terms of maximum drawdown, CM dropped -71.70% vs KNSA's -83.06%.
CM currently has the higher Sharpe Ratio (3.65 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CM and KNSA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer